e cost of such treatment could be up to $5k annually and we expect the drug to hit the US market in 2020 and China approximately one year later. 3 IFage EFTA R1_02139718 EFTA02714284 BREMNER CAPITAL MANAGEMENT Tekmira Pharmaceuticals March 2014 • TKM — ALDH2 is a unique application of RNAi a